Half-year report · HY
7071.TEDINET S100Y3ZE
Period2025-10-01 → 2026-03-31
Filed2026-05-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥25.6bn | 2025-10-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥49.2bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥23.8bn | 2024-10-01 → 2025-03-31 | Cons. | Net sales |
| Operating income | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | ¥3.7bn | 2024-10-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥6.3bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥3.8bn | 2024-10-01 → 2025-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.8bn | 2025-10-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥3.8bn | 2024-10-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.7bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.9bn | 2025-10-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2024-10-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥83.9bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥83.9bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥82.7bn | at 2025-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥46.0bn | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥47.8bn | at 2025-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥37.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥36.1bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥35.2bn | at 2025-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.2bn | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥10.8bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥9.2bn | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥10.8bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥11.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.9bn | at 2024-09-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥3.8bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥6.0bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥3.3bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥3.2bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.9bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥2.2bn | 2025-10-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥6.4bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.5bn | 2024-10-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥19.41 | 2025-10-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.52 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥27.55 | 2024-10-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥19.41 | 2025-10-01 → 2026-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥37.51 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥27.55 | 2024-10-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 45.2% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.0% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 23
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-10-01 → 2026-03-31 | −¥2m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-10-01 → 2026-03-31 | −¥2m |
| Reconciling Itemsreconciling | segment profit | 2025-10-01 → 2026-03-31 | ¥0 |
| Comprehensive Medical Supportreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥569m |
| Comprehensive Medical Supportreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥567m |
| Comprehensive Medical Supportreportable segment | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥2m |
| Comprehensive Medical Supportreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥324m |
| Ishinkanreportable segment | revenue | 2025-10-01 → 2026-03-31 | ¥25.0bn |
| Ishinkanreportable segment | revenue external | 2025-10-01 → 2026-03-31 | ¥25.0bn |
| Ishinkanreportable segment | segment profit | 2025-10-01 → 2026-03-31 | ¥2.5bn |
| —segment total | revenue | 2025-10-01 → 2026-03-31 | ¥25.6bn |
| —segment total | revenue external | 2025-10-01 → 2026-03-31 | ¥25.6bn |
| —segment total | revenue intersegment | 2025-10-01 → 2026-03-31 | ¥2m |
| —segment total | segment profit | 2025-10-01 → 2026-03-31 | ¥2.8bn |
| Comprehensive Medical Supportreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥228m |
| Comprehensive Medical Supportreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥228m |
| Comprehensive Medical Supportreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥68m |
| Ishinkanreportable segment | revenue | 2024-10-01 → 2025-03-31 | ¥23.6bn |
| Ishinkanreportable segment | revenue external | 2024-10-01 → 2025-03-31 | ¥23.6bn |
| Ishinkanreportable segment | segment profit | 2024-10-01 → 2025-03-31 | ¥3.7bn |
| —segment total | revenue | 2024-10-01 → 2025-03-31 | ¥23.8bn |
| —segment total | revenue external | 2024-10-01 → 2025-03-31 | ¥23.8bn |
| —segment total | segment profit | 2024-10-01 → 2025-03-31 | ¥3.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 480
| Item | Context | Value | Unit |
|---|---|---|---|
| Net increase decrease in short term loans payable fin cf | InterimDuration | -2699000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1InterimDuration | 3860000000 | JPY |
| Proceeds from long term loans payable fin cf | InterimDuration | 3907000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1InterimDuration | -2008000000 | JPY |
| Repayment of long term loans payable fin cf | InterimDuration | -2888000000 | JPY |
| Repayments of lease obligations fin cf | Prior1InterimDuration | -92000000 | JPY |
| Repayments of lease obligations fin cf | InterimDuration | -100000000 | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | Prior1InterimDuration | － | JPY |
| Proceeds from issuance of subscription rights to shares fin cf | InterimDuration | 10000000 | JPY |
| Cash dividends paid fin cf | Prior1InterimDuration | -391000000 | JPY |
| Cash dividends paid fin cf | InterimDuration | -390000000 | JPY |
| Other net fin cf | Prior1InterimDuration | -390000000 | JPY |
| Other net fin cf | InterimDuration | － | JPY |
| Net cash provided by used in financing activities | Prior1InterimDuration | 6534000000 | JPY |
| Net cash provided by used in financing activities | InterimDuration | -2160000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1InterimDuration | 2945000000 | JPY |
| Net increase decrease in cash and cash equivalents | InterimDuration | -1623000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 8868000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 10833000000 | JPY |
| Cash and cash equivalents | Prior1InterimInstant | 11814000000 | JPY |
| Cash and cash equivalents | InterimInstant | 9210000000 | JPY |
| Merchandise and finished goods | Prior1YearInstant | 25000000 | JPY |
| Merchandise and finished goods | InterimInstant | 36000000 | JPY |
| Supplies ca | Prior1YearInstant | 5000000 | JPY |
| Supplies ca | InterimInstant | 5000000 | JPY |
| Personal expenses sga | Prior1InterimDuration | 1476000000 | JPY |
| Personal expenses sga | InterimDuration | 1648000000 | JPY |
| Provision for bonuses sga | Prior1InterimDuration | 110000000 | JPY |
| Provision for bonuses sga | InterimDuration | 133000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 23592000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 228000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReportableSegmentsMember | 23820000000 | JPY |
| Revenues from external customers | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1InterimDuration | 23820000000 | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReportableSegmentsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | Prior1InterimDuration | － | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 23592000000 | JPY |
| Net sales | Prior1InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 228000000 | JPY |
| Net sales | Prior1InterimDuration_ReportableSegmentsMember | 23820000000 | JPY |
| Net sales | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Net sales | Prior1InterimDuration | 23820000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 3675000000 | JPY |
| Operating income | Prior1InterimDuration_jpcrp040300-ssr_E35140-000ComprehensiveMedicalSupportReportableSegmentMember | 68000000 | JPY |
| Operating income | Prior1InterimDuration_ReportableSegmentsMember | 3743000000 | JPY |
| Operating income | Prior1InterimDuration_ReconcilingItemsMember | － | JPY |
| Operating income | Prior1InterimDuration | 3743000000 | JPY |
| Revenues from external customers | InterimDuration_jpcrp040300-ssr_E35140-000IshinkanReportableSegmentMember | 25033000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |